SCHEMBL3671938

SCHEMBL3671938

CCCc1n[nH]c2c(=O)n(C)c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.63
PDE3B Q13370 4/20 0.63
PDE3A Q14432 4/20 0.63
PDE1A P54750 3/20 0.63
PDE1B Q01064 3/20 0.63
PDE1C Q14123 3/20 0.63
PDE4B Q07343 2/20 0.63
PDE2A O00408 1/20 0.63
ABCC4 O15439 1/20 0.63
ABCC5 O15440 1/20 0.63
PDE6D O43924 1/20 0.63
PDE8A O60658 1/20 0.63
PDE9A O76083 1/20 0.63
ABCB11 O95342 1/20 0.63
CYP3A4 P08684 1/20 0.63
HTR1A P08908 1/20 0.63
PDE6A P16499 1/20 0.63
PDE6G P18545 1/20 0.63
PDE4A P27815 1/20 0.63
ADORA2A P29274 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7778185 0.92 PDE5A (0.54) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL4653199 0.91 PDE5A (0.53) PDE5APDE3BPDE3APDE1APDE1B
Citric Acid SCHEMBL18919600 0.91 PDE5A (0.68) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL1906070 0.87 PDE5A (0.60) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL970 0.87 PDE5A (0.74) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL7019550 0.82 PDE5A (0.46) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL7362346 0.81 PDE5A (0.43) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL14685954 0.81 KDM4E (0.48) PDE5APDE3BPDE3APDE1APDE2A
SCHEMBL3671939 0.79 PDE5A (0.55) PDE5APDE3BPDE3APDE1APDE1B
SCHEMBL14685941 0.78 KDM4E (0.46) PDE5APDE1APDE2AABCC5PDE9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2556820-A2 COMPOSITION CONTAINING PDE5 INHIBITOR FOR RELIEVING SKIN WRINKLES SK Chemicals, Co., Ltd. (KR) 2013-02-13 EP claimed
WO-2013067309-A1 METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF MELANOCORTIN RECEPTOR AGONIST COMPOUNDS XION PHARMACEUTICAL CORPORATION (US) 2013-05-10 WO disclosed
EP-2556820-A2 COMPOSITION CONTAINING PDE5 INHIBITOR FOR RELIEVING SKIN WRINKLES SK Chemicals, Co., Ltd. (KR) 2013-02-13 EP disclosed
EP-2240467-A1 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME Renovis, Inc. (US) 2010-10-20 EP disclosed
WO-2009089057-A1 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME RENOVIS, INS. (US) 2009-07-16 WO disclosed
EP-2024272-A2 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME Renovis, Inc. (US) 2009-02-18 EP disclosed
EP-1868590-A2 METHOD OF INCREASING TESTOSTERONE AND RELATED STEROID CONCENTRATIONS IN WOMEN Unimed Pharmaceuticals, Inc. (US) 2007-12-26 EP disclosed
WO-2007133637-A2 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME RENOVIS, INC. (US) 2007-11-22 WO disclosed
WO-2006113242-A2 METHOD OF INCREASING TESTOSTERONE AND RELATED STEROID CONCENTRATIONS IN WOMEN UNIMED PHARMACEUTICALS, INC. (US) 2006-10-26 WO disclosed